Hodgkin Lymphoma
Feature
Blood cancer patient takes on bias and ‘gaslighting’
Having battled Hodgkin lymphoma and the health care system itself, a young public relations specialist is on a mission.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
AFib risk with cancer drugs underestimated
Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials.
Conference Coverage
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Conference Coverage
Steep cost of surviving childhood HL: Epigenetic aging
New research found accelerated epigenetic aging in most adults who survived pediatric Hodgkin lymphoma.
Conference Coverage
ASH 2022: New clinical data challenge long-held assumptions
Fresh research to be unveiled at the 2022 American Society of Hematology conference seems to overturn conventional wisdom across a range of issues...
Feature
Drug shortages plague hematology, but preparedness helps
The plight of desperate patients is getting attention – and some remedies.
Feature
Woman who faked cancer gets 5 years in prison
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
From the Journals
‘Unprecedented crisis’: Hodgkin drug shortage persists
Supply chain problems have triggered shortages of a drug to treat Hodgkin lymphoma, igniting a search for substitutes.